Early switch from intravenous to oral antibiotics: Guidelines and implementation in a large teaching hospital;Vroege omzetting van intraveneuze naar orale antibiotica bevorderd door invoering van een richtlijn in een opleidingsziekenhuis

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 47, 1999, Pages 2370-2374

  Sevinc F ^a   Prins, J M ^a   Koopmans, R P ^a   Langendijk, P N J ^a   Bossuyt, P M M ^a   Dankert, J ^a   Speelman, P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG ADMINISTRATION; DRUG USE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TEACHING HOSPITAL;

EID: 0033589721     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mandell LA, Bergeron MG, Cribble MJ, Jewesson PJ, Low DE, Marrie TJ, et al. Sequential antibiotic therapy: effective cost management and patient care. Canadian Journal of Infectious Diseases 1995;6:306-15.
2. MacGregor RR, Graziani AL. Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis 1997; 24:457-67.
3. Hamilton-Miller JMT. Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clinical Microbiology and Infection 1996;2:12-9.
4. Sevinç F, Prins JM, Koopmans RP, Langendijk PNJ, Dankert J, Speelman P. Vroege omzetting van intraveneuze naar orale antibiotica: 'switchtherapie'. Ned Tijdschr Geneeskd 1999;143:2364-9.
5. Dagan R, Syrogiannopoulos G, Ashkenazi S, Engelhard D, Einhorn M, Gatzola-Karavelli M, et al. Parenteral-oral switch in the management of paediatric pneumonia. Drugs 1994;47(Suppl 3):43-51.
6. Siegel RE, Halpern NA, Almcnoff PL, Lee A, Cashin R, Greene JG. A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest 1996;110:965-71.
7. Gangji D, Jacobs F, Jonckheer J de, Coppens L, Serruys E, Hanotte F. et al. Randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia. Am J Med 1989;87(Suppl 5A):206S-8S.
8. Khan FA, Basir R. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 1989;96:528-37.
9. Regnier B. Étude comparative du eéfixime en relais oral de la ceftriaxone intraveineuse versus ceftriaxone seule dans le traitement des infections urinaires hautes sévères. Presse Méd 1989;18:1617-21.
10. Paladino JA, Sperry HE, Backes JM, Gelber JA, Serrianne DJ, Cumbo TJ, el al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991;91:462-70.
11. Vogel F. Efficacy and tolerance of cefotaxime followed by oral cefixime versus cefotaxime alone in patients with lower respiratory tract infections. The multicenter trial group. Current Therapeutic Research 1994;55(Suppl A):42-8.
12. Kalager T, Andersen BM, Bergan T, Brubakk O, Bruun JN, Doøskeland B, et al. Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety. Scand J Infect Dis 1992;24:637-46.
13. Fass RJ, Plouffe JF, Russell JA. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med 1989;87(Suppl 5A):164S-8S.
14. Cox CE. Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections. Am J Med 1989;87(Suppl 5A):157S-9S.
15. Amodio-Groton M, Madu A, Madu CN, Briceland LL, Seligman M, McMaster P, et al. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis. Ann Pharmacother 1996;30:596-602.
16. Chan R, Hemeryck L, O'Regan M, Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. BMJ 1995;310:1360-2.
17. Vogel F. Sequential therapy in the hospital management of lower respiratory infections. Am J Med 1995;99(Suppl 6B):14S-9S.
18. Seto WH, Ching TY, Kou M, Chiang SC, Lauder IJ, Kumana CR. Hospital antibiotic prescribing successfully modified by 'immediate concurrent feedback'. Br J Clin Pharmacol 1996;41:229-34.
19. Okpara AU, Maswoswe JJ, Stewart K. Criteria-based antimicrobial iv. to oral conversion program. Formulary 1995;30:343-8.
20. Hunter KA, Dormaier GK. Pharmacist-managed intravenous to oral step-down program. Clin Ther 1995;17:534-40.
21. Allen B, Naismith NW, Manser AJ, Moulds RFW. A campaign to improve the timing of conversion from intravenous to oral administration of antibiotics. Australian Journal of Hospital Pharmacy 1992; 22:434-9.
22. Gyssens IC, Brock PJ van den, Kullberg BJ, Hekster YA, Meer JWM van der. Optimizing antimicrobial therapy. A method for antimicrobial drug use evaluation [letter]. J Antimicrob Chemother 1992;30:724-7.
23. Davis R, Bryson HM. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections. Pharmaco-Economics 1994;6:249-69.
24. Gyssens IC, Lennards CA, Hekster YA, Meer JWM van der. Cost of hospital antimicrobial chemotherapy. A method for global cost calculation. Pharm Weekbl Sci 1991;13:248-53.
25. Feely J, Chan R, Cocoman L, Mulpeter K, O'Connor P. Hospital formularies: need for continuous intervention. BMJ 1990;300:28-30.
26. Fraser GL, Stogsdill P, Dickens jr JD, Wennberg DE, Smith jr RP, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689-94.
27. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996;124:884-90